• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 295/15 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Patent holdings for IPC class C07D 295/15

Total number of patents in this class: 344

10-year publication summary

25
35
17
26
18
21
23
29
27
30
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
The Board of Trustees of the University of Illinois
2723
13
The Board of Regents of the University of Texas System
2229
9
Tetraphase Pharmaceuticals, Inc.
51
8
Novartis AG
10623
6
Yissum Research Development Company of The Hebrew University of Jerusalem Ltd.
1349
6
Pharmatrophix, Inc.
22
5
Ramot at Tel-Aviv University Ltd.
1503
5
University of Tennessee Research Foundation
754
5
Beam Therapeutics Inc.
248
5
Contemporary Amperex Technology (Hong Kong) Limited
3845
5
Rohm and Haas Company
2934
4
Dow Global Technologies LLC
10555
4
President and Fellows of Harvard College
6036
4
JSR Corporation
2542
4
The Cooper Health System
40
4
SRI International
1000
4
West China Hospital, Sichuan University
204
4
Sanofi
4131
4
BASF SE
21087
3
Massachusetts Institute of Technology
10143
3
Other owners 239